The ATMP landscape has been growing at a rapid rate since 2017, a momentous year in which three cell and gene therapies were approved—all the first of their kind.
Resistance isn’t the only problem that can result from antimicrobial overuse. Through decades of research, scientists have begun to realize that microbes, both in our environment and in our bodies, play an important role in maintaining our health.
Parkinson’s Disease. Diabetes. Muscular dystrophy. These diseases all lack cures, but they also share another important similarity: the quest for their cures is playing out in the field of ATMPs.